AMH Levels Change During Treatment With GnRh Agonist

• Status: Completed
• Trial end date: 2014-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

To evaluate the variation of AMH levels in women undergoing treatment with GnRHa, and to assess whether this variation correlates with changes in the antral and pre-antral follicle ultrasonographic count (AFC).

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Magna Graecia
• Treatments: Deslorelin; Hormones

Criteria

Inclusion Criteria:

• Patients waiting for surgery for benign conditions such as uterine fibroids and endometriosis, undergoing preoperative treatment with two consecutive doses of GnRHa at a dose of 11.25 every three months

• 18 to 45 years aged patients

• Regular menstrual intervals between 22 and 35 days

• Expressed written consent for the study entry

Exclusion Criteria:

• Patients who do not consent to pharmacological preparation with GnRHa

• Estrogen-progestin therapy in the 2 months before enrollment

• Autoimmune diseases, chronic , metabolic, systemic and endocrine disorders, including hyperandrogenism, hyperprolactinemia, diabetes mellitus and thyroid disease.

• Hypogonadotropic hypogonadism

• Majors clinical conditions